A multiscale mathematical model of tumour invasive growth by Peng, Lu et al.
A multiscale mathematical model of tumour
invasive growth
Lu Peng∗ Dumitru Trucu† Ping Lin‡
Alastair Thompson§ Mark A. J. Chaplain¶
November 6, 2018
Abstract
Known as one of the hallmarks of cancer [30], cancer cell invasion
of human body tissue is a complicated spatio-temporal multiscale pro-
cess which enables a localised solid tumour to transform into a systemic,
metastatic and fatal disease. This process explores and takes advantage of
the reciprocal relation that solid tumours establish with the extracellular
matrix (ECM) components and other multiple distinct cell types from the
surrounding microenvironment. Through the secretion of various prote-
olytic enzymes such as matrix metalloproteinases (MMP) or the urokinase
plasminogen activator (uPA), the cancer cell population alters the config-
uration of the surrounding ECM composition and overcomes the physical
barriers to ultimately achieve local cancer spread into the surrounding
tissue.
The active interplay between the tissue-scale tumour dynamics and
the molecular mechanics of the involved proteolytic enzymes at the cell-
scale underlines the biologically multiscale character of invasion, and raises
the challenge of modelling this process with an appropriate multiscale
approach. In this paper, we present a new two-scale moving boundary
model of cancer invasion that explores the tissue scale tumour dynamics
in conjunction with the molecular dynamics of the urokinase plasminogen
activation system. Building on the multiscale moving boundary method
proposed in [58], the modelling that we propose here allows us to study the
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changes in tissue scale tumour morphology caused by the cell-scale uPA
micro-dynamics occurring along the invasive edge of the tumour. Our
computational simulation results demonstrate a range of heterogeneous
dynamics which are qualitatively similar to the invasive growth patterns
observed in a number of different types of cancer, such as the tumour
infiltrative growth patterns discussed in [33].
Keywords: Cancer invasion Multiscale modelling uPA system
1 Introduction
Cancer is a complicated disease that involves many cross-related processes oc-
curring over several spatial scales, ranging from genes to cells to tissues. The
abilities of cancer cells to activate invasion and metastasis, to sustain prolifera-
tive signalling, to evade growth suppressors, to enable replicative immortality,
to induce angiogenesis, and to resist cell death, have been initially identified as
the six main hallmarks of cancer [30]. A growing knowledge about cancer over
the last decade has shed more light on the whole picture of the disease and an-
other four hallmarks were added, namely: the ability of cancer to avoid immune
destruction, to deregulate cellular energetics, to develop tumour-promoting in-
flammations, alongside genome instability and mutations [31].
Highlighted as one of the hallmarks of cancer, cancer cell invasion is a land-
mark event that transforms a locally growing tumour into a systemic, metastatic
and fatal disease. The past four decades have witnessed great scientific efforts
focussed on gaining a better understanding of the processes involved during can-
cer invasion, which is of highly importance in designing early detection strategies
and attempting effective therapies.
A malignant tumour includes a complex heterotypic community of cells (such
as cancer cells, immuno-inflamatory cells, stromal cell, fibroblasts, endothelial
cells, macrophages) that are mixed with ECM. This community is enhanced by
vastly complex signalling pathways underpinning intense molecular processes
that mediates the crosstalk between the various cell populations composing the
tumours, such as the interaction between the cancer cells and the peritumoural
stroma cells occurring during cancer invasion [31, 43, 49, 34, 35]. As one of the
main factors that affect the way the cancer cell migrate and invade, the peritu-
moural ECM not only plays the role of a scaffold for the tissues and physical
barriers during cell migration but also conveys the signalling pathway processes,
enabling the cells to communicate. These give rise to specific conditions within
the tumour microenvironment that locally regulate cell migration, proliferation
and differentiation. Specifically, the secretion of proteolytic enzymes such as
urokinase plasminogen activator (uPA) and matrix metalloproteinases (MMPs)
by the tumour cells and interactions of these enzymes with the ECM compo-
nents lead to proteolytic degradation and remodelling of the ECM and represent
a key step in the cancer invasion process.
In order to decipher the mechanisms behind the complicated processes in-
volved in cancer invasion, clinical investigations and experimental observations
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carried out over the past few decades have started being increasingly accompa-
nied by mathematical modelling [2, 5, 11, 16, 25, 28, 45, 46, 60]. These initial
modelling attempts used reaction-diffusion systems to describe the interaction
between malignant and normal cells and focused on several important invasion
aspects, leading to the first qualitative mathematical modelling approaches and
paving the way towards a better understanding of the contribution of proteolytic
enzymes in cancer invasion. This was further explored with modelling focused
the role of proteolytic activities of some specific hydrolytic enzymes such as
urokinase plasminogen activator (uPA) and matrix metalloproteinases (MMPs)
in tumour invasive behaviour [4, 6, 9, 15, 18, 45, 46]. For instance, while [15]
proposed a system of reaction-diffusion-taxis partial differential equations to ex-
plore the role of the uPA system (including uPA, uPA-inhibitors, plasmin and
host tissue) in cancer invasion, the model introduced in [18] evaluates the role
of two types of simultaneously expressed MMPs on cancer growth and spread
i.e., membrane-bound matrix MT1-MMP and soluble MMP-2.
Alongside the chemotactic and haptotactic movement assumed in all the
models mentioned above, cell-cell and cell-matrix adhesion were also recognised
as playing a crucial role in the growth and development of carcinomas [11].
Advances in addressing the importance of cell-adhesion in the cancer invasion
process were obtained via several models based on systems of non-local integro-
differential equations [7, 14, 20, 27] that account for dynamic interactions within
an appropriately small sensing radius R between potentially mutating cancer cell
populations, ECM, and the involved matrix degradation enzymes.
Since the local tissue invasion of a malignant tumour could be regarded also
as a free moving boundary problem, several appropriate numerical techniques
were considered in the computational modelling of cancer invasion. Particu-
larly, the level-set method was intensely used to study solid tumour growth in
homogeneous microenvironments [24, 37, 38, 39, 63]. A new ghost cell/level
set method (based of a nonlinear nutrient equation coupled with a pressure
equation with geometry-dependent jump boundary conditions) was developed
in [40] and applied to models of tumour invasive growth in complex, hetero-
geneous tissues. This model was later extended into an improved model of
tumour invasion including the process of tumour-induced angiogenesis [41]. Fi-
nally, alongside the level-set method, multiphase models based on the theory
of mixtures were also developed and used to investigate tumour growth and
spread [10, 13, 22, 48, 61, 62]. In these approaches, the tumour was regarded
as a system consisting of different phases (e.g. cellular phase, liquid phase, etc)
and the development of a solid tumour was modelled by exploring the mass and
momentum balances alongside the constitutive laws that distinguish the phases
in the system.
However, while recognizing the multiscale nature of cancer growth and spread,
over the past two decades or so most computational and mathematical modelling
has focused mainly on one scale, either at the tissue, cell or molecular scale, with
the first attempts towards linking these scales being revised in [19]. Recently,
following a series of important developments within the general multiscale frame-
work, and based on strong insights from atomistic-to-continuum methods [36],
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homogenization techniques [3, 57], and heterogeneous multiscale finite element
methodology [1, 21, 51], a genuinely new multiscale moving boundary model
for cancer invasion that links the tissue, cellular and subcellular scales was pro-
posed in [58]. In this new framework, PDE modelling at the tissue scale for the
cell population dynamics and PDE modelling at the cell scale for the molecular
mechanics of the proteolytic enzymes population are linked together in a two-
scale model through top-down and bottom-up permanent links. The top-down
link provides the source for the micro-scale dynamics, which is induced in a
non-local manner by the macro-dynamics. On the other hand, the bottom-up
link enables the micro-dynamics to provide the macro-dynamics with a law for
the macro-scale boundary movement, whose direction and displacement magni-
tude is determined at microscale. This is fundamentally different from previous
modelling perspectives such as the one-scale modelling presented in [5], or the
one proposed in [50] where the authors considered continuous modelling at the
microscale but an individual-based model at the macroscale and where no top-
down links were assumed.
In this paper we propose a novel multiscale mathematical model of cancer
invasion that explores the tissue scale cancer progression in conjunction with the
cell-scale dynamics of the urokinase plasminogen activation system. Building
on the multiscale moving boundary method proposed in [58], the new modelling
that we propose here allows us to study the changes in tissue scale (macro) tu-
mour morphology caused by the cell-scale uPA micro-dynamics occurring in a
cell-scale (micro) neighbourhood of the invasive edge of the tumour. Assuming
the uPA model developed in [4, 15] for the tissue scale dynamics, we derive gov-
erning laws for the degrading enzymes cell-scale dynamics arising in the close
proximity of the tumour interface. While this results in prescribing an appro-
priate form for the top-down link between the macro- and micro- dynamics,
by exploring the spatial interaction between the uPA micro-dynamics and the
surrounding ECM from the peritumoural region we obtain a bottom-up link
between the micro- and macro- dynamics. This allows us to describe the evolu-
tion of tumour invasive edge morphology and enables computational predictions
for the changes occurring in the macroscopic pattern of cancer during the local
invasion process.
2 Biological Background: Components of the
uPA System and their Functions
Proteolytic degradation and remodelling of the extracellular matrix is essen-
tial for cancer cell invasion. It enables cancer cells to proliferate and migrate
through surrounding tissue. In this context, one of the first steps of invasion is
the production and secretion of proteolytic enzymes, i.e., urokinase plasminogen
activator (uPA) and matrix metalloproteinases (MMPs) by cancer cells. These
enzymes interact with the dynamics of the ECM macromolecules and pave the
way for cancer invasion. Specifically, the uPA enzymatic system mainly con-
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sists of the urokinase receptor (uPAR), urokinase plasminogen activator (uPA),
the matrix-like protein vitronectin (VN), plasminogen activator inhibitor type1
(PAI-1), and the degrading enzyme plasmin.
Urokinase plasminogen activator (uPA). uPA is an extracellular serine pro-
tease produced by cells. Two major functional domains of the uPA molecule
are the protease domain and the growth factor domain. The protease part ac-
tivates plasminogen and turns it into plasmin, which is able to digest basement
membrane and extracellular matrix proteins. The growth factor domain has
no protease activity but can bind a specific high affinity cell-surface receptor,
uPAR. Finally, uPA has a zymogen form, pro-uPA, which can be activated by
plasmin and binds to uPAR.
Urokinase plasminogen activator receptor (uPAR). uPAR is a high affinity cell-
surface receptor of uPA (and of its zymogen form pro-uPA), which via the bind-
ing process localises the uPA and pro-uPA to the cell surface. Importantly,
uPAR contains another binding site for the ECM component called vitronectin
(VN), and since VN and uPA binding sites are distinct, uPAR can simulta-
neously bind both ligands, allowing coordinated regulation of proteolysis, cell
adhesion, and signalling.
uPAR expression during ECM remodelling is well-controlled under normal
conditions, for example, in gestational tissues during embryo implantation and
placental development and in keratinocytes during epidermal would healing.
uPAR is also expressed in many human cancers. It indicates poor prognosis
and in some cases is predictive of invasion and metastasis. Importantly, uPAR
expression in tumours can occur in tumour cells and/or tumour-associated stro-
mal cells, such as fibroblasts and macrophages. Moreover, there is a certain
crosstalk between these two binding processes, as the ligand-binding of uPA to
uPAR enhances the VN binding by uPAR [54].
Vitronectin (VN). VN is an abundant versatile glycoprotein found in serum
and the ECM and promotes cell adhesion and spreading. Vitronectin binds
strongly to glass surfaces, as the name indicates (vitro = glass), and it has bind-
ing sites for several ligands, including heparin, urokinase plasminogen activator
receptor (uPAR), plasminogen activator inhibitor type-1(PAI-1), and integrins,
such as αvβ3. When vitronectin binds to uPAR, it is thought to bring PAI-
1 closer to uPA, thereby promoting inhibition and clearance of uPA from the
receptor.
Urokinase plasminogen activator Inhibitor-1(PAI-1) One of the inhibitors of
urokinase plasminogen activator, PAI-1, belongs to the serpin (serine protein
inhibitors) family and it is believed to be the most abundant, fast-acting in-
hibitor of uPA in vivo. It can specifically bind to soluble and membrane-bound
uPA to inhibit plasminogen activation. When PAI-1 binds to the uPA/uPAR
complex, it triggers the internalisation of the uPA/uPAR/PAI-1 complex by
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receptor-mediated endocytosis, meaning that the complex will be dissociated
and PAI-1 and uPA will be digested, but the receptor will be recycled to the
cell surface. This process helps with the clearance of PAI-1 from the vicinity of
the cell surface. Additionally, as a major binding protein of VN, PAI-1 competes
with uPAR for binding to VN.
Plasmin. Plasmin is a widespread enzyme that cleaves many extracellular ma-
trix proteins, such as fibronectin, laminin, vitronectin and thrombospondin. In
addition, plasmin can also activate many matrix metalloproteinases (MMPs),
enhancing even more the degradation of extracellular matrix. It can also influ-
ence the composition of the extracellular environment by affecting the activity of
cytokines and growth factors, for example, decreasing the activation of TGF-β1
[59].
3 Mathematical Modelling
In this section, we will detail the three main components of the uPA multiscale
model that we propose for cancer invasion, namely: the macroscopic dynamics,
the microscopic dynamics and regulation of the tumour boundary relocation.
Thus, the description will cover the model at both the macro level (tissue-scale)
and the micro level (cell-scale), and will explore the link between these two
biological scales.
3.1 The macroscopic dynamics
For the tumour macroscopic dynamics, we adopt here the modelling hypotheses
formulated in [15]. We denote the cancer cell density by c, the extracellu-
lar matrix density by v (without making the distinction between ECM and its
component VN), the urokinase plasminogen activator (uPA) concentration by u,
the plasminogen activator inhibitor (PAI-1) concentration by p and the plasmin
concentration by m. Further, since we assume a fixed average number of recep-
tors uPAR located on each cancer cell surface, there is no explicit modelling of
uPAR. Therefore, the concentration of uPAR is considered to be proportional
to the cancer cell density. Another important assumption is that the supply
of plasminogen is unlimited in this model. Finally, the macroscopic model is
obtained by accounting for the biological considerations described in previous
section in conjunction with the following presumptions:
The cancer cell dynamics. It is assumed that cancer cell migration is mainly
governed by diffusion, chemotaxis due to uPA, and PAI-1 and haptotaxis due
to VN and other ECM components. Additionally, a logistic growth law is used
to model cancer cell proliferation. Thus, the mathematical equation for cancer
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cell density that is considered here is as follows:
∂c
∂t
= Dc∆c︸ ︷︷ ︸
diffusion
−∇ · [ χuc∇u︸ ︷︷ ︸
uPA-chemo
+ χpc∇p︸ ︷︷ ︸
PAI-1-chemo
+ χvc∇v︸ ︷︷ ︸
VN-hapo
] + µ1c(1− c
c0
)︸ ︷︷ ︸
profieration
, (1)
where Dc is the diffusion coefficient of cancer cells, χu and χp are the chemo-
taxis coefficients relevant to uPA and PAI-1 respectively, χv is the VN-mediated
haptotaxis rate, µ1 is the cancer cell proliferation rate, and c0 is the maximum
carrying capacity for cancer cells.
The ECM/VN dynamics. As ECM is not assumed to move, we rule out any
migration terms in the governing law. While VN (which is an important ECM
component) is degraded in contact with enzymes m, the binding of PAI-1 to uPA
inhibits the activation of plasminogen, leading to the protection of VN and other
ECM molecular constituents and indirectly contributing to their production.
Simultaneously, the binding of PAI-1 to VN results in less binding to cell-surface
receptors such as uPAR, and so, through the regulation of cell-matrix-associated
signal transduction pathways, this inhibits the production of VN. Therefore,
assuming a logistic ECM remodelling, the governing equation for ECM is given
by
∂v
∂t
= − δvm︸︷︷︸
degradation
+ φ21up︸ ︷︷ ︸
uPA/PAI-1
− φ22vp︸ ︷︷ ︸
PAI-1/VN
+µ2v(1− v
v0
)︸ ︷︷ ︸
remodelling
. (2)
where δ is the rate of ECM degradation by plasmin, φ21 is the binding rate of
PAI-1 to uPA, φ22 is the binding rate of PAI-1 to VN, and µ2 is the matrix
remodelling rate.
The uPA dynamics. The mathematical modelling of the uPA concentration
dynamics accounts for the following aspects. While being produced by the
cancer cells and removed from the system due to its binding with PAI-1 and
uPAR, per unit time the uPA exercises a local diffusion. Therefore, this can be
formalised mathematically as follows:
∂u
∂t
= Du∆u︸ ︷︷ ︸
diffusion
− φ31pu︸ ︷︷ ︸
uPA/PAI-1
− φ33cu︸ ︷︷ ︸
uPA/uPAR
+ α31c︸︷︷︸
production
, (3)
where Du is the diffusion coefficient, φ31 and φ33 are binding rates of uPA/PAI-
1 and uPA/uPAR accordingly, and α31 is the production rate of uPA by the
cancer cells.
The PAI-1 dynamics. Similarly, the equation for PAI-1 simply includes a dif-
fusion term with coefficient Dp, removal caused by binding to uPA and VN with
binding rates φ41 and φ42 respectively, and production as a result of plasmin
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formation at a rate α41. Thus, these considerations lead us to the following
governing equation:
∂p
∂t
= Dp∆p︸ ︷︷ ︸
diffusion
− φ41pu︸ ︷︷ ︸
uPA/PAI-1
− φ42pv︸ ︷︷ ︸
PAI-1/VN
+ α41m︸ ︷︷ ︸
production
. (4)
The plasmin dynamics. The evolution of plasmin concentration is modelled
as follows. While assuming that per unit time this exercises a local diffusion,
we consider that the binding of uPA to uPAR provides an opportunity for
pericellular proteolytic activity through plasminogen activation leading to plas-
min formation. Moreover, the binding of PAI-1 to VN indirectly enhances the
binding of uPA to uPAR, therefore bringing additional contribution to plasmin
formation. Thus, these assumptions give us the following evolution law:
∂m
∂t
= Dm∆m︸ ︷︷ ︸
diffusion
+ φ52pv︸ ︷︷ ︸
PAI-1/VN
+ φ53cu︸ ︷︷ ︸
uPA/uPAR
− φ54m︸ ︷︷ ︸
degradation
, (5)
where Dm is the diffusion coefficient, φ52 and φ53 are the binding rates of PAI-
1/VN and uPAR/uPA accordingly, and φ54 is the rate of decay of plasmin.
To summarise the macro-dynamics, the dimensionless mathematical model
of the uPA system adopted here is the one that was initially proposed in [15],
namely:
∂c
∂t
= Dc∆c︸ ︷︷ ︸
diffusion
−∇ · [ χuc∇u︸ ︷︷ ︸
uPA-chemo
+ χpc∇p︸ ︷︷ ︸
PAI-1-chemo
+ χvc∇v︸ ︷︷ ︸
VN-hapo
] + µ1c(1− c)︸ ︷︷ ︸
profieration
, (6)
∂v
∂t
= − δvm︸︷︷︸
degradation
+ φ21up︸ ︷︷ ︸
uPA/PAI-1
− φ22vp︸ ︷︷ ︸
PAI-1/VN
+µ2v(1− v)︸ ︷︷ ︸
remodelling
, (7)
∂u
∂t
= Du∆u︸ ︷︷ ︸
diffusion
− φ31pu︸ ︷︷ ︸
uPA/PAI-1
− φ33cu︸ ︷︷ ︸
uPA/uPAR
+ α31c︸︷︷︸
production
, (8)
∂p
∂t
= Dp∆p︸ ︷︷ ︸
diffusion
− φ41pu︸ ︷︷ ︸
uPA/PAI-1
− φ42pv︸ ︷︷ ︸
PAI-1/VN
+ α41m︸ ︷︷ ︸
production
, (9)
∂m
∂t
= Dm∆m︸ ︷︷ ︸
diffusion
+ φ52pv︸ ︷︷ ︸
PAI-1/VN
+ φ53cu︸ ︷︷ ︸
uPA/uPAR
− φ54m︸ ︷︷ ︸
degradation
. (10)
3.2 The microscopic dynamics
Turning now our attention to the micro-scale setting, in the following we will
derive and propose a system of three coupled PDEs to describe the micrody-
namics of the plasminogen activation system taking place within a cell-scale
-neighbourhood P of the tumour invasive edge ∂Ω(t0) (which is introduced in
Appendix 6).
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Assuming that PAI-1 and uPAR are uniformly expressed on the cell surface
of various cell types in the tumour, this system will capture the leading edge
micro-dynamics of the uPA, PAI-1 and plasmin by accounting for the following
biological considerations. On one hand, the urokinase plasminogen activator
(uPA) is assumed to bind to the cancer surface receptor uPAR to activate
plasminogen, leading to degradation of pericellular ECM through a series of
proteolytic activities. On the other hand, the membrane-bound MMPs (such as
MT1-MMP) are secreted from within the tumour cell population distributed on
the outer proliferating rim along the entire tumour periphery. Their region of
proteolytic activities is therefore restricted around the tumour interface [18, 53].
Thus, based on these considerations, we propose a coupled governing law for
the leading edge microdynamics, which is detailed as follows:
The uPA microdynamics. In each micro region Y the dynamics of the uPA
molecular population is governed by a diffusion process whose source is induced
from the tumour cell macro-dynamics. At each point y ∈ Y , a source of uPA
arises as a collective contribution of the tumour cells distributed within a certain
neighbouring area within the tumour’s outer proliferating rim. Therefore, this
source is denoted by fY (·, ·)× [0,∆t] : Y → R+ and is defined by:
f Y1 (y, τ) =
{ 1
λ(B(y,γ)∩Ω(t0))
∫
B(y,γ)∩Ω(t0)
c (x, t0 + τ) dx, y ∈ Y ∩ Ω(t0),
0, outside cancer,
(11)
where λ(·) is the standard Lebesgue measure, and γ represents the maximal
thickness of the outer proliferating rim. Thus, per unit time, under the presence
of source (11) the uPA is locally diffusing and is binding to both PAI-1 and
uPAR, and so its microdynamics can be formally written as:
∂u
∂τ
= Du∆u︸ ︷︷ ︸
diffusion
− φ31pu︸ ︷︷ ︸
uPA/PAI-1
+ ( α31︸︷︷︸
production
− φ33u︸︷︷︸
uPA/uPAR
)f Y1 (y, τ) (12)
The PAI-1 microdynamics. The equation for PAI-1 accounts for diffusive mo-
tion, production due to plasmin activation, and loss due to binding with uPA
and VN. Specifically, the binding between PAI-1 and VN is as a collective effect
of the ECM distribution within Y . Therefore, proceeding similarly to the case
of the source term in (11), we define
f Y2 (y, τ) =
1
λ(B(y, 2))
∫
B(y,2)
v (x, t0 + τ) dx, y ∈ Y, (13)
which finally enable us to write the following governing law for the PAI-1 mi-
crodynamics, namely:
∂p
∂τ
= Dp∆p︸ ︷︷ ︸
diffusion
− φ41pu︸ ︷︷ ︸
uPA/PAI-1
−φ42p f Y2 (y, τ)︸ ︷︷ ︸
PAI-1/VN
+ α41m︸ ︷︷ ︸
production
. (14)
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The plasmin microdynamics. For the spatio-temporal evolution of plasmin, it
is assumed that, per unit time, this exercises a local diffusion in the presence of
the following source and decay circumstances. Considering that the binding of
uPA to uPAR is required to provide the cell surface with a potential proteolytic
activity, the plasmin source accounts on one hand on the contribution of the
binding uPA/uPAR. On the other hand, as PAI-1 collectively competes with
uPAR for binding to VN, the binding of PAI-1 to VN gives more opportunities
to uPAR to bind with uPA, and indirectly results in more plasmin formation.
Finally, plasmin can be deactivated either by degradation or by the action of
the plasmin inhibitor α2-antiplasmin. Thus, the equation that we obtain to
describe these biological interactions is:
∂m
∂τ
= Dm∆m︸ ︷︷ ︸
diffusion
+φ52p f
Y
2 (y, τ)︸ ︷︷ ︸
PAI-1/VN
+φ53u f
Y
1 (y, τ)︸ ︷︷ ︸
uPA/uPAR
− φ53m︸ ︷︷ ︸
degradation
(15)
In summary, the leading edge microdynamics is therefore given by the fol-
lowing system:
∂u
∂τ
= Du∆u︸ ︷︷ ︸
diffusion
− φ31pu︸ ︷︷ ︸
uPA/PAI-1
+ ( α31︸︷︷︸
production
− φ33u︸︷︷︸
uPA/uPAR
)f Y1 (y, τ), (16)
∂p
∂τ
= Dp∆p︸ ︷︷ ︸
diffusion
− φ41pu︸ ︷︷ ︸
uPA/PAI-1
−φ42p f Y2 (y, τ)︸ ︷︷ ︸
PAI-1/VN
+ α41m︸ ︷︷ ︸
production
, (17)
∂m
∂τ
= Dm∆m︸ ︷︷ ︸
diffusion
+φ52p f
Y
2 (y, τ)︸ ︷︷ ︸
PAI-1/VN
+φ53u f
Y
1 (y, τ)︸ ︷︷ ︸
uPA/uPAR
− φ54m︸ ︷︷ ︸
degradation
. (18)
3.3 The macroscopic tumour boundary relocation induced
by the leading edge micro-dynamics
Following the multiscale approach described in Appendix 6, the set of points
{x∗Y } on the boundary of tumour at the current time moves towards a set of
new spatial positions {x˜∗Y } to form the new boundary at the next multiscale-
stage, provided that the local transitional probability q∗ is in agreement with
the circumstances in the surrounding peritumoural microenvironment. When
the invading strength is above a tissue threshold, the point x∗Y will relocate
to a new position x˜∗Y following a direction and displacement magnitude that
represents the choreographic movement of all the points from the part of the
invasive edge captured by the micro-domain Y .
As described in Appendix 6.2, on any micro-domain Y , provided that a
sufficient amount of plasmin has been produced across the invading edge, it is
the pattern of the front of the advancing spatial distribution of plasmin that
characterises ECM degradation. Therefore, the movement direction and dis-
placement magnitude of the part of the invading edge of the tumour caputred
by the current micro-domain Y will be determined by the spatial distribution
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pattern of the advancing front of plasmin m(·, τf ) in the peritumoural region.
As detailed in Appendix 6.2, these movement characteristics are obtained by
accounting the contribution of all peaks (baricentred at the spatial points yl) at
the front of advancing plasmin that are above the mean value of the entire mass
of plasmin produced on Y \Ω(t0) and are located at the furthest away Euclidean
distance from {x∗Y }. Thus, under these conditions, the moving direction ηY
and displacement magnitude ξY derived in Appendix 6.2 in (35)-(36) have the
following expressions:
ηY = x
∗
Y + ν
∑
l∈Iδ
(∫
Dl
m(y, τf )dy
)
(yl − x∗Y ), ν ∈ [0,∞],
ξY :=
∑
l∈Iδ
∫
Dl m(y, τf )dy∑
l∈Iδ
∫
Dl m(y, τf )dy
∣∣−−−→x∗Y yl∣∣.
Finally, the transitional probability q∗ defined in (37) is a quantification of
the amount of plasmin in Y \Ω(t0) relative to the total amount of plasmin
concentration in Y and characterizes the invading strength. Therefore, the
point x∗Y will exercise the movement into the new spatial position x˜
∗
Y if and
only if q(x∗Y ) := q
∗(Y ) exceeds a certain tissue local threshold ω(β, Y ) ∈
(0, 1) associated with the micro-domain Y under a given state of favourable
conditions β.
4 Multiscale Computational Simulation Results
The multiscale model of cancer invasion that we proposed here was numerically
solved in a rectangular region Y := [0, 4 × [0, 4]. For all our simulations, we
discretise the entire cube Y uniformly, using the spatial mesh size: ∆x = ∆y =

2 = 0.03125. In this context, the initial conditions for the macro-dynamics
are specified as follows. The cancer cell population on the initially considered
tumour region Ω(0) := B((2, 2), 0.5) is assumed to be given by a translated
Gaussian centred at (2, 2) and mollified to 0 after a radius of 0.5, namely:
c(x, 0) =
(
exp
(− ||x−(2,2)||22√
∆x∆y
)− exp(−28.125))(χ
B((2,2),0.5−γ) ∗ ψγ
)
2
, x ∈ Y,
(19)
where ψγ is the mollifier defined in (40)-(41) with γ <<
∆x
3 . Further, the initial
macroscopic conditions for the enzymatic components entering the uPA system
are considered as follows:
u(x, 0) = 1− 12c(x, 0), x ∈ Y
p(x, 0) = 12c(x, 0), x ∈ Y
m(x, 0) = 120c(x, 0), x ∈ Y
(20)
11
Figure 1: Initial conditions of the distributions of cancer cells (left column) and
ECM (right column) and the invasive boundary of the tumour (white line) for
the homogeneous case (top row) and the heterogeneous case(bottom row).
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At the same time, in all the subsequent simulations, we consider the following
homogeneous and heterogeneous initial condition for ECM, namely:
homogeneous case: v(x, 0) = 1− c(x, 0), x ∈ Y,
heterogeneous case: v(x, 0) = 1+0.3 sin (4pi||x||2)+sin (4pi||(4,0)−x||2)2 , x ∈ Y.
(21)
Figure 1 shows the initial conditions (19) and (21) of ECM and cancer cell
distributions for both homogeneous and heterogeneous cases that are used in
all the simulations presented in this paper.
Finally, in the absence of medical data, for the tissue threshold ω(β, Y )
controlling whether or not a point on the boundary will exercised the movement
according to the direction and displacement magnitude defined in Appendix 6.2,
we adopt the following functional form:
ω(β, Y ):=

sin
(
pi
2
(
1− 1β
vω(t0)(x
∗
Y ,t0+∆t)
sup
ξ∈∂Ω(t0)
vΩ(t0)(ξ,t0+∆t)
)
if
vω(t0)(x
∗
Y ,t0+∆t)
sup
ξ∈∂Ω(t0)
vΩ(t0)(ξ,t0+∆t)
≤β
sin
(
pi
2(1−β)
(
vω(t0)(x
∗
Y ,t0+∆t)
sup
ξ∈∂Ω(t0)
vΩ(t0)(ξ,t0+∆t)
−β
)
if
vω(t0)(x
∗
Y ,t0+∆t)
sup
ξ∈∂Ω(t0)
vΩ(t0)(ξ,t0+∆t)
>β
(22)
where β ∈ (0, 1) is a parameter that controls a certain “optimal level” of ECM
degradation and consider this as being the indicator of the most favourable
invasion conditions at the level of tumour and tissue microenvironment. This
functional form of ω rules out any invasion if either a complete destruction or a
very superficial degradation of the surrounding ECM is performed by the MDEs.
This is due to the fact that while for invasion the cancer cells need consider-
able level of the ECM degradation, a total destruction of the surrounding ECM
structure prevents them to advance further into the tissue, as they need some of
the ECM components to adhere to in order to migrate. Finally, while this func-
tional form of the tissue threshold aimed to showcase the proposed multiscale
modelling framework, future work seeks to infer ω(·, Y ) from medical imaging
data of the peritumoural tissue.
The following figures show the simulation results of the evolving cancer cell
and ECM spatial distributions and of the invasive tumour boundary at macro-
time stage 20, 40, 60. The images are presented in two columns, with the left
columns representing the cancer cell distribution and right columns showing the
corresponding ECM concentrations. Furthermore, all these images include the
tumour boundary.
In the subsequent simulations, for the macroscopic part of the model, except
otherwise stated, we will generally be using the following basic set of parameter
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values P :
Dn= 4.3×10−3, χu= 3.05×10−2, χp= 3.75×10−2, χv= 2.85×10−2,
µ1 = 0.25, δ= 8.15, φ21 = 0.75, φ22 = 0.55,
µ2 = 0.15, Du= 2.5× 10−3, φ31 = 0.75, φ33 = 0.3,
α31 = 0.215, Dp= 3.5× 10−3, φ41 = 0.75, φ42 = 0.55,
α41 = 0.5, Dm= 4.91× 10−3, φ52 = 0.11, φ53 = 0.75,
φ54 = 0.5. (23)
which are detailed in Table 1 in Appendix 8. However, in order to investi-
gate different cancer growth patterns, as described in the following simulation,
we will perform numerical tests also for slightly changed values for the diffu-
sion coefficient of cancer cells Dc, the ECM proliferation rate µ2, or the ECM
degradation rate δ. Also, we will explore a range of values for parameter β, to
highlight the correlation between changes in tissue microenvironment conditions
conditions and the resulting cancer invasion patterns.
In order to analyse the effect of each variables (namely, ECM initial con-
dition, cancer cell diffusion coefficient, ECM proliferation & degradation rates,
and threshold coefficient), we will split the results into four groups as follows:
ECM initial condition. To investigate what effect do different ECM initial con-
ditions have on the whole dynamics of the model, we apply the same threshold
function for both homogeneous and heterogeneous ECM scenario.
The ECM heterogeneity gives rise to a tumour-tissue interaction that is
naturally more complex than in the case of homogeneous ECM. A direct conse-
quence of this is that the ECM heterogeneity triggers a corresponding intrinsic
variability in the tissue thresholds, which explore the peritumoural tissue con-
ditions that the cancer interacts with during invasion. This results in a higher
degree of complexity in the spatial structure of the regions with most favourable
conditions for the tumour to progress further in the surrounding region, within
the directions and displacement magnitudes specified by the microscale dynam-
ics. Ultimately, this gives rise to a higher level of fingering and infiltrative
patterns in the heterogeneous case as opposed to the homogeneous case. This is
confirmed by our results presented in Figure 3 that are obtained for the hetero-
geneous ECM, which exhibit more “fingered” and infiltrative spreading of the
tumour compared with those obtained in the homogeneous ECM case shown in
Figure 2. This type of fingering patterns are often observed in medical imaging
data, such as the one reported in the case of oesophageal and lung cancer by
the authors in [33] and [42], respectively.
Cancer cell diffusion coefficient Dc. As was demonstrated in [32] and [44], the
chemotaxis terms in the cancer cell equation (6) are the main causes of the
occurrence of heterogeneous patterns inside the tumour domain. Therefore, if
the cancer cell diffusion coefficient (Dc) is increased to be one order magnitude
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Figure 2: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line)
at various macro-micro stages: Stage 20, 40, 60. Starting from the homo-
geneous initial conditions shown in Figure 1, these results were obtained for
Dc = 4.3× 10−3, β = 0.775, µ2 = 0.01 and δ = 1.5.
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Figure 3: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line) at
various macro-micro stages: Stage 20, 40, 60. Starting from the heterogeneous
initial conditions shown in Figure 1, these results were obtained for Dc = 4.3×
10−3, β = 0.775, µ2 = 0.01 and δ = 1.5.
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larger than the chemotaxis coefficients (χu and χp), which becomes the domi-
nant mechanism of cell movement, then no heterogeneous dynamics will occur
inside the tumour as shown in Figure 4. In Figure 5, the chemotaxis coefficients
are one order magnitude larger than the diffusion coefficient, and as a conse-
quence we obtain heterogeneous pattern formation of cancer cells, which leads
to a more dynamic tumour boundary deformation.
ECM proliferation rate µ2 & degradation rate δ. From all the simulation results
presented so far, we conclude that the degradation of ECM facilitates cancer
invasion. However, as shown also in several interdisciplinary biological investi-
gations [25, 26, 55], the invasion process will stop where ECM is degraded a lot.
This captures the biological scenario in 2D that when cell-matrix adhesion is too
low, no focal adhesions or stress fibres are formed, and the cells do not move.
In order to investigate the effect of ECM proliferation and degradation on the
invasion process, we compare two groups of parameters: 1) µ2 = 0.01, δ = 1.5
(non-zero proliferation rate with relatively large degradation rate, Figure 6);
2) µ2 = 0, δ = 0.75 (no proliferation with relatively small degradation rate,
Figure 7). From these two groups of images, we observe that when prolifera-
tion is present and the degradation rate is relatively large, deformations of the
boundary is not as dynamic as that when the proliferation term is absent with
a relatively small degradation rate. The reason could be that the proliferation
term will reduce the degree of heterogeneity of the distribution of ECM, which
leads to a less fingered spreading of the cancer cell population.
Figure 8 shows the results of simulations at the macro-micro stage 60 where
the ECM proliferation rate parameter µ2 was increased over a range of values in
the interval [0.0005, 0.005]. The figures show that, over the range chosen, there
is little difference in either the overall extent of invasion or the morphology
of the invading cancer. Figure 9 shows the results of simulations at the same
macro-micro stage 60 where the degradation parameter δ was increased over
the interval [0.5, 1]. The figures show that, over the range chosen, the extent
of the invasion is similar, but the morphology of the invading cancer changes
slightly from a more fingered boundary to a less fingered boundary. Finally, as
the two parameters µ2 and δ are varied, both Figure 8 and Figure 9 exhibit
spatial consistency aspects in the invasion pattern.
Threshold coefficient β. Finally, Figure 10 shows us comparative results at
macro-micro stage 60 for several values of the threshold coefficients β in the
interval [0.7625, 0.7875]. Since β controls the “optimal level” of ECM density
for cancer cells to migrate, its variation gives us different invasion morphologies,
as expected. Again, as we noticed also in the cases of Figure 8 and Figure 9,
a quick comparison between consecutive rows of images (from top to bottom)
in Figure 10 seems to indicate a certain degree of consistency in the changes
occurring in the tumour morphology and “fingered” boundary deformations
with respect to increasing β parameter. This consistency aspect is currently
under investigation and will form the topic of a separate research work.
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Figure 4: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line) at
various macro-micro stages: Stage 20, 40, 60. Starting from the heterogeneous
initial conditions shown in Figure 1, these results were obtained for Dc = 1.4×
10−2, β = 0.775, µ2 = 0 and δ = 0.75.
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Figure 5: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line) at
various macro-micro stages: Stage 20, 40, 60. Starting from the heterogeneous
initial conditions shown in Figure 1, these results were obtained for Dc = 4.3×
10−3, β = 0.775, µ2 = 0 and δ = 0.75.
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Figure 6: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line) at
various macro-micro stages: Stage 20, 40, 60. Starting from the heterogeneous
initial conditions shown in Figure 1, these results were obtained for Dc = 4.3×
10−3, β = 0.7625, µ2 = 0.005 and δ = 1.5.
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Figure 7: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line) at
various macro-micro stages: Stage 20, 40, 60. Starting from the heterogeneous
initial conditions shown in Figure 1, these results were obtained for Dc = 4.3×
10−3, β = 0.7625, µ2 = 0 and δ = 0.75.
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Figure 8: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line)
at macro-micro stage 60. Starting from the heterogeneous initial conditions
shown in Figure 1, these results were obtained for Dc = 4.3× 10−3, β = 0.7625,
δ = 1.5, and for rows 1 to 3 of images we consider µ2 = 0.0005, µ2 = 0.001, and
µ2 = 0.005, respectively. 22
Figure 9: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line)
at macro-micro stage 60. Starting from the heterogeneous initial conditions
shown in Figure 1, these results were obtained for Dc = 4.3 × 10−3, µ2 = 0,
β = 0.7625, and for rows 1 to 3 of images we consider δ = 0.5, δ = 0.75, and
δ = 1, respectively. 23
Figure 10: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line)
at macro-micro stage 60. Starting from the homogeneous initial conditions
shown in Figure 1, these results were obtained for Dc = 4.3 × 10−3, δ = 1.5,
µ2 = 0.01, and for rows 1 to 3 of images we consider β = 0.7625, β = 0.775,
and β = 0.7875, respectively. 24
5 Conclusion
In this paper, we presented and developed a mathematical model of cancer in-
vasion based on the previous work in [4, 15] and [58]. We adapted and extended
the two-scale technique in [58] to cope with the different settings that enable
the coupling of the finite-difference uPA macro-solver and a new finite element
micro-solver developed for the newly proposed leading edge micro-dynamics.
This enabled us to simulate the multiscale process of cancer invasion by ex-
ploring the link between the macroscopic dynamics of the spatio-temporal dis-
tribution of cancer cells and ECM taking place on a macroscopic domain, and
the matrix degrading enzymes microdynamics developed on the microscopic
domains that are in close proximity to tumour boundary.
We derived a new governing law for the micro-dynamics based exclusively on
the molecular mechanics of the uPA system occurring in close proximity to the
tumour boundary. This is based on the dynamics of the uPA system including
uPA, the inhibitor uPA-1 and plasmin, and considers the source terms related
to macroscopic components, i.e. cancer cells and ECM molecules, in a collec-
tive fashion and we solve this new microscopic uPA system by finite element
method. While this is sourced from within the macrodynamics via a top-down
link, in our multiscale method (described in Appendix 6.2) the microdynamics
occurring at the cell-scale neighborhood of the tumour is represented back at the
macroscale through a bottom-up feedback by defining the movement direction
and displacement magnitude of the tissue-scale tumour boundary. By coupling
this new microscopic governing law for the leading edge microdynamics with the
macroscopic model for the uPA system and cancer invasion proposed in [4, 15],
we are able to capture an important class of multiscale dynamic interactions
between cancer cells, ECM molecules, cancer associated matrix degrading en-
zymes, and the peritumoural tissue conditions, leading to significant changes in
tumour morphology during invasion.
From the computational simulation results of our model, we can see that the
extended two-scale technique coupled with the uPA system and more specific
modelling of the pericellular proteolytic activities, gives more adverse dynam-
ics in the invading cancer. Values of the ECM initial condition, the cancer
cell diffusion coefficient, the threshold coefficient, and the ECM proliferation &
degradation rates all have an impact on the deformations of the tumour bound-
ary. While for simulating the proposed non-dimensional model we considered
functional formulations for the initial conditions and tissue thresholds, future
work will attempt to assimilate the heterogeneity of ECM and as well as the
peritumoural tissue conditions from imaging data. Finally, concerning the tran-
sitional probability that arises naturally at the micro-scale and intervenes in the
bottom-up link between micro and macro scales, while the simulations presented
in this paper are deterministic, future work will assess the stochastic character
of the overall model.
The conclusions that can be drawn from the qualitative results presented in
this paper are: 1) a heterogeneous ECM initial condition leads to more fingered
spreading of the tumour compared with that in the homogeneous ECM; 2) in
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order to obtain heterogeneous patterns of cancer cells inside the tumour region,
chemotaxis must be dominant to drive the cells migration; 3) the changes of
threshold coefficient will definitely affect the boundary deformations, and there
is a tendency that the increase of β reduces the number of ‘fingers’ of the in-
terface; 4) without a proliferation term of ECM coupled with a relatively small
degradation rate, deformations of the boundary show more fingering. However,
further investigations are required to analyse the observed fingering. For in-
stance, the dependence of the width of the fingers on the size of the microscale
and potentially on other regulatory parameters remains an open question and
is an important objective of a future work on the propose modelling framework.
It is useful to compare these results with other models of cancer growth
and invasion, particularly those that adopt an alternative modelling approach
such as hybrid continuum-discrete, cellular-Potts or cellular automaton, as well
as partial differential equations (PDE) models. Many PDE models of solid
tumour growth and development (including invasion) have modelled cell-cell
adhesion at the outer boundary (or invading edge) of the tumour as a surface-
tension-like force [11, 12]. A reduction in surface tension i.e. interpreted as a
loss of cell-cell adhesion then leads to an instability at the invading edge which
manifests itself in a subsequent growth consisting of finger-like protrusions. This
effect was shown computationally by [17] and [39] who demonstrated a range
of fingering patterns as a cell adhesion parameter was varied. Similar spectra
of invasive patterns have been observed when adopting either a cellular-Potts
approach [47] or a hybrid continuum-discrete approach [6] i.e., by varying a key
cell-cell adhesion parameter of the model, invasive fingering patterns can either
be enhanced or suppressed. In the specific case of glioma invasion, four different
approaches – PDE, cellular-Potts, lattice-gas automaton, cellular automaton –
have each investigated the role of cell-cell adhesion and compared computational
simulation results with experimental data [8, 23, 52, 56]. Given these results,
we are currently extending our current model to include cell-cell adhesion.
As the main purpose of this work was to formulate a novel non-dimensional
two-scale modelling platform that simultaneously explores spatio-temporal dy-
namics at both macro-scale (cell population level) and micro-scale alongside the
links in between the two scales, the simulations presented here have a qualita-
tive character. Future work will explore the possibilities of dimensionalising and
calibrating the proposed multiscale model with measured data at both macro-
scopic (tissue-scale) and microscopic (cell-scale) levels to obtain quantitative
simulation that we could compare with clinical observations.
The two-scale modelling modelling described provides a useful mathematical
platform to capture and investigate processes at different levels during cancer
invasion. However, further details remain to be explained on the dynamics and
interactions of the tumour cell community at the macro-level and the micro-
level as well as regarding the links in between these two scales. Various avenues
could be pursued to extend our modelling by exploring for instance other ways
to determine the cancer cell population macro-dynamics (for example, change
the definition of the threshold function ω characterising the interaction with the
peritumoural tissue) or by accounting for more complex signalling mechanisms
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in the establishment of more detailed micro-dynamics as well as the appropriate
top-down and bottom-up links between these different levels (scales) of the
invasion process.
6 Appendix: The Two-Scale Computational Mod-
elling Method
In the following we will briefly present the technique introduced in [58] and ad-
just this with all the details to our new situation. For completion, we introduce
here all the necessary notations and describe the defining principles that are
referred to in the paper, as well as the relevant considerations and explanations
concerning our new model.
6.1 Preliminary considerations and notations
It is assumed that the domain within which the cancer and extracellular matrix
exists is a maximal reference spatial cube Y ⊂ Rn(n = 2, 3) with its centre at
the origin. Given a fixed  representing a negative power of 2 (i.e., 0 <  < 1),
the initial Y is uniformly decomposed -size cubes, Y , whose union will be
referred to as an -resolution of Y . For any Y from the decomposition, the
“half-way shifted” cubes in the direction ie¯1 + je¯2 + ke¯3 given by any triplet
(i, j, k) ∈ {(i, j, k)|i, j, k ∈ {−1, 0, 1}} are defined as
Y i
2 ,
j
2 ,
k
2
= Y +
(ie¯1 + je¯2 + ke¯3)
2
, (24)
where,
e¯1 : = e1, e¯2 : = e2, and, e¯3 : =
{
e3 for N = 3,
0 for N = 2,
(25)
and {e1, e2, e3} is the standard Euclidean basis of R3. The family of all these
−cubes is denoted by F , i.e.,
F :=
⋃
i,j,k∈{−1,0,1}
{
Y i
2 ,
j
2 ,
k
2
∣∣Y is in the -resolution of Y }. (26)
In Figure 11, the notations mentioned so far are illustrated schematically.
In order to capture mathematically the microdynamics that occur in a cell-
scale neighbourhood of the tumour boundary ∂Ω(t0), out of the initial family
F , we will focus our attention of the subfamily denoted by FΩ(t0) which consists
of only the −cubes that cross the interface ∂Ω(t0) and have exactly one face
included in the interior of Ω(t0), namely
FΩ(t0) := {Y ∈ F|Y ∩ (Y \Ω(t0)) 6= ∅,
and Y has only one face included in int(Ω(t0))}, (27)
27
Figure 11: Schematic diagram showing the cubic region Y centred at the origin
∈ R3. The dashed blue lines represent the Euclidean directions {e1, e2, e3}, the
pink region illustrates the cancer cluster Ω(t0), and the solid blue line represents
the family of microscopic cubic domains Y placed at the boundary ∂Ω(t0).
where int(Ω(t0)) is the topological interior of Ω(t0) with respect to the natural
topology on Rn. In this context, for each Y ∈ FΩ(t0), we have the following
face-notations:
ΓintY denotes the face of Y that is included in int(Ω(t0)),
Γj,⊥Y , j = 1, ..., 2
N−1, denote the faces of Y that are perpendicular to ΓintY
Γ
‖
Y denotes the face of Y that is parallel to Γ
int
Y .
(28)
These are illustrated schematically in Figure 12.
Furthermore, for each Y ∈ FΩ(t0), the topological closure of the only con-
nected component of Ω(t0)∩ Y that is confined between [∂Ω(t0)]Y and ΓintY is
denoted by [Ω(t0)]Y . Moreover, denoting by [∂Ω(t0)]Y the connected compo-
nent part of ∂Ω(t0) ∩ Y with the property that
[∂Ω(t0)]Y ∩ Γj,⊥Y 6= ∅ for any j = 1, 2, ..., 2n−1, (29)
we can observe that [∂Ω(t0)]Y represents the part of ∂Ω(t0) ∩ Y that cor-
responds to [Ω(t0)]Y , and is actually the only connected component of this
intersection that has property (29). Finally, using this observation, for the cur-
rently fixed , the subfamily denoted by P consisting of all those −cubes that
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Figure 12: Schematic diagram illustrating the notations introduced in (28),
(32). For the arbitrary microdomain Y ∈ P, we indicate with a black arrow
the features: ΓintY , Γ
j1,⊥
Y , and Γ
j2,⊥
Y , j1, j2 ∈ {1, ..., 2N−1}, Γ‖Y , xcY , µY , and
x∗Y . The arbitrary cube Y ∈ P∗ is shown in green, while the corresponding
half-way shifted Y signi
2
∈ Pthat are not chosen in P∗ are shown in the blue
dashed line.
have [Ω(t0)]Y not touching Γ
‖
Y is selected as follows:
P := {Y ∈ FΩ(t0)| [Ω(t0)]Y ⊂ Y and [∂Ω(t0)]Y ∩ Γ‖Y = ∅}. (30)
Leaving now  to take all the negative powers of 2, the union⋃
∈{2−k | k∈N}
P
provides an infinite covering of ∂Ω(t0). Since ∂Ω(t0) is compact, using standard
compactness arguments, a finite complete sub-covering of ∂Ω(t0) that consist
only of small cubes an equal size ∗ is denoted by P∗ , i.e.,
∂Ω(t0) ⊂
⋃
Y ∈P∗
Y. (31)
Together with this finite complete covering P∗ of the tumour interface ∂Ω(t0),
at each time of the tumour evolution we obtain also the size of the micro-scale ∗
[58]. For simplicity, in this paper, the size of the cell-scale ∗ will still be denoted
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by . Finally, for each Y ∈ P∗ , we distinguish the following topological details:
xcY denotes the centre of the face Γ
int
Y ,
µY , is the line that passes through x
c
Y and is perpendicular on Γ
int
Y
x∗Y ∈ [∂Ω(t0)]Y which will be referred to as the “midpoint” of [∂Ω(t0)]Y ,
represents the point from the intersection µY ∩ [∂Ω(t0)]Y that is located
at the smallest distance with respect to xcY .
(32)
The well-posedness of these topological features is discussed in [58], and these
are illustrated in Figure 12.
6.2 The multiscale moving boundary approach for the pro-
posed cancer invasion model
In the following, we will explain how the set of midpoints {x∗Y }Y ∈P∗ defined
on the boundary of tumour at the current time moves to a set of new spatial
positions {x˜∗Y }Y ∈P∗ to form the new boundary at the very next time, by
describing the movement of one such midpoint x∗Y ∈ [∂Ω(t0)]Y for any Y ∈
P∗ .
Based on biological observations that, on any micro domain Y , provided
that a sufficient amount of plasmin has been produced across the invading edge
and it is the pattern of the front of the advancing spatial distribution of plasmin
that characterised ECM degradation, therefore it is assumed that each boundary
midpoint x∗Y ∈ [∂Ω(t0)]Y will be potentially relocated in a movement direction
and by a certain displacement magnitude dictated by the spatial distribution of
plasmin obtained via the micro process on Y at the final micro-time τf := ∆t,
namely, m(·, τf ). In the following, we explain how the movement direction and
displacement magnitude are defined for each x∗Y ∈ [∂Ω(t0)]Y .
For any given threshold δ > 0 and any fixed Y ∈ P∗ , the regularity prop-
erty of Lebesgue measure [29] is used to select the first dyadic decomposition
{Dj}j∈Jδ of Y such that
λ
(
[Y \Ω(t0)] \
⋃
{j∈Jδ |Dj⊂Y \Ω(t0)}
Dj
)
≤ δ. (33)
which simply means that Y \Ω(t0) is approximated with accuracy δ by the
union of all the dyadic cubes that this includes. Once this dyadic decompo-
sition is selected, we denote by yj the barycenters of Dj , for all j ∈ Jδ. As
discussed in [58] for all Y ∈ P∗ , this provides a resolution at which we read the
further away part of the level set 1λ(Y \Ω(t0))
∫
Y \Ω(t0)m(y, ·)dy in the distribu-
tion of the advancing degrading enzymes m(·, ·) outside Ω(t0) in radial direction
with respect to the midpoint x∗Y . Therefore, this enable us to locate dyadic
pixels Dl that support the peaks at the tip of the plasmin front with significant
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contribution in degrading the ECM. Hence, at the final microscopic time τf , the
pixels supporting these peaks are therefore selected as
Iδ :=

l ∈ Jδ
∣∣∣∣∣∣∣∣∣∣∣∣
∃r ∈ S1 such that, if the index i ∈ Jδ has the properties:
1)Di ∩ {x ∈ Rn |x = x∗Y + αr, α ∈ R} 6= ∅,
2)Di ⊂ Y \Ω(t0),
3) 1λ(Di)
∫
Di m(y, τf )dy ≥ 1λ(Y \Ω(t0))
∫
Y \Ω(t0)m(y, τf )dy,
then
l = argmax{d(x∗Y , yi) | i ∈ Jδ satisfies:1), 2), and3)}

,
(34)
where S1 ⊂ Rn is represents the unit sphere, and d(·, ·) is the Euclidean distance
on Rn. Thus, cumulating the driving ECM degradation forces spanned by each
front peak of plasmin given by the dyadic pixels Dl with l ∈ Iδ in the direction
of the position vectors
−−−−→
x∗Y , yl and appropriately representing the amount of
plasmin that each Dl supports, the revolving direction of movement ηY for the
potential displacement of x∗Y is given by:
ηY = x
∗
Y + ν
∑
l∈Iδ
(∫
Dl
m(y, τf )dy
)
(y − x∗Y ), ν ∈ [0,∞]. (35)
Further, the displacement magnitude of the point x∗Y is defined as:
ξY :=
∑
l∈Iδ
∫
Dl m(y, τf )dy∑
l∈Iδ
∫
Dl m(y, τf )dy
∣∣−−−→x∗Y yl∣∣. (36)
Finally, as debated in [58], although a displacement magnitude and a moving
direction is derived for each x∗Y , this will only exercise the movement if and
only if the ECM degradation were of a certain local strength. The strength of
ECM degradation within Y is explored by the transitional probability
q∗ :
∑ ⋃
Y ∈P∗
Y
→ R+
defined as
q∗(G) :=
1∫
G
m(y, τf )dy
∫
G\Ω(t0)
m(y, τf )dy, for all G ∈
∑ ⋃
Y ∈P∗
Y

(37)
where
∑( ⋃
Y ∈P∗
Y
)
represents the Borel σ−algebra of ⋃
Y ∈P∗
Y . Locally, in
each Y , equation (37) is in fact a quantification of the amount of plasmin
in Y \Ω(t0) relative to the total amount of plasmin concentration in Y . In
conjunction with the local tissue conditions, this characterises whether the point
x∗Y is likely to relocate to the new spatial position x˜
∗
Y or not.
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Now, by assuming that the point x∗Y is moved to the position x˜
∗
Y if and
only if q∗(x∗Y ) := q
∗(Y ) exceeds a certain threshold ωY ∈ (0, 1), we find that
the new boundary ∂Ω(t0 + ∆t) will be the interpolation of the following set of
points:
{x∗Y |Y ∈ P∗Y and q(x∗Y ) < ωY } ∪ {x˜∗Y |Y ∈ P∗Y and q(x∗Y ) ≥ ωY } (38)
Finally before moving to the next time-step of the whole macro-micro two
scale system, we replace the initial conditions of the macroscopic dynamics with
the solution at the final time of the previous invasion step as follows:
cΩ(t0+∆t)(x, t0) := c(x, t0 + ∆t)(χΩ(t0)\
⋃
Y∈P∗
Y
∗ ψγ),
vΩ(t0+∆t)(x, t0) := v(x, t0 + ∆t)(χY \ ⋃
Y∈P∗
Y
∗ ψγ),
uΩ(t0+∆t)(x, t0) := u(x, t0 + ∆t)(χΩ(t0)\
⋃
Y∈P∗
Y
∗ ψγ),
pΩ(t0+∆t)(x, t0) := p(x, t0 + ∆t)(χΩ(t0)\
⋃
Y∈P∗
Y
∗ ψγ),
mΩ(t0+∆t)(x, t0) := m(x, t0 + ∆t)(χΩ(t0)\
⋃
Y∈P∗
Y
∗ ψγ). (39)
Here χ
Ω(t0)\
⋃
Y∈P∗
Y
∗ψγ and χY \ ⋃
Y∈P∗
Y
∗ψγ are the characteristic functions
corresponding to the sets Ω(t0)\
⋃
Y ∈P∗
Y and Y \ ⋃
Y ∈P∗
Y , and choosing γ  3 ,
ψγ : Rn → R+ is constructed as a smooth compact support function with
sup(ψγ) = {z ∈ Rn|||z||2 ≤ γ}. This is defined by the standard mollifier
ψ : Rn → R+, namely,
ψγ(x) :=
1
γn
ψ(
x
γ
), (40)
and,
ψ(x) :=

exp( 1
x2−1 )∫
{z∈Rn|||z||2≤γ}
exp( 1
z2−1 )dz
if ||x||2 < 1,
0 if ||x||2 ≥ 1,
(41)
Then, the invasion process will continue on the new expanded domain Ω(t0)
with the macroscopic system and the new initial conditions in (39) at macro-
level followed by proteolytic microprocesses around its boundary, which again
governs the movement of the boundary of the next time multiscale stage.
7 Appendix: Description of the multiscale nu-
merical approach
We compute and solve the multiscale model in a two-dimensional setting by
using computational approach based on a finite difference scheme for macrody-
namics and finite element approximation for the microdynamics occurring on
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each of the boundary Y microdomains. In the following subsections we de-
tail the computational approach and present the steps of the overall multiscale
algorithm.
7.1 The macroscopic stage of the numerical scheme
Since the macroscopic dynamics are taking place in the cube Y , we discretise the
entire Y by considering a uniform spatial mesh of size h := 2 , i.e., ∆x = ∆y = h.
And, the time interval [t0, t0 + ∆t] is discretised in k uniformly distributed time
steps, i.e., using the uniform time step δτ := ∆tk . The temporal discretisation
of the reaction-diffusion system (6) - (10) that we used here is a second-order
trapezoidal scheme, (7); while the diffusion term and haptotactic terms are
approximated with a second-order midpoint rule. For instance, for the diffusion
and haptotactic terms involved in (6), we approximate∇·(∇c)ni,j and∇·(c∇v)ni,j
as follows:
∇·(∇c)ni,j = div(∇c)ni,j
'
(cx)
n
i+ 12 ,j
− (cx)ni− 12 ,j
∆x
+
(cy)
n
i,j+ 12
− (cy)ni,j− 12
∆y
,
and
∇·(c∇v)ni,j=div(c∇v)ni,j
'
cn
i+ 12 ,j
(vx)
n
i+ 12 ,j
−cn
i− 12 ,j
(vx)
n
i− 12 ,j
∆x
+
cn
i,j+ 12
(vy)
n
i,j+ 12
−cn
i,j− 12
(vy)
n
i,j− 12
∆y
,
where 
cn
i,j+ 12
:=
cni,j+c
n
i,j+1
2 ,
cn
i,j− 12
:=
cni,j+c
n
i,j−1
2 ,
cn
i+ 12 ,j
:=
cni,j+c
n
i+1,j
2 ,
cn
i− 12 ,j
:=
cni,j+c
n
i−1,j
2 ,
are the midpoint approximations for c and
(cy)
n
i,j+ 12
:=
cni,j+1−cni,j
∆y ,
(cy)
n
i,j− 12
:=
cni,j−cni,j−1
∆y ,
(cx)
n
i+ 12 ,j
:=
cni+1,j−cni,j
∆x ,
(cx)
n
i− 12 ,j
:=
cni,j−cni−1,j
∆x ,
, and

(vy)
n
i,j+ 12
:=
vni,j+1−vni,j
∆y ,
(vy)
n
i,j− 12
:=
vni,j−vni,j−1
∆y ,
(vx)
n
i+ 12 ,j
:=
vni+1,j−vni,j
∆x ,
(vx)
n
i− 12 ,j
:=
vni,j−vni−1,j
∆x ,
represent the central differences for spatial derivatives of c and v. Note that
n = 0, 1, ..., k are index of time step, and (i, j) are spatial nodes where i = 1, ...q
are the indices for the x-direction and j = 1, ...q are the indices for the y-
direction. The diffusion terms in equations (8) -(10) are approximated in the
same way as it is in equation (6) and (7).
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7.2 The computational microscopic scheme and its rela-
tion to the macroscopic level
In this section, we describe our computational scheme for the micro scale dy-
namics occurring on each microdomains Y ∈ P∗ , which are cubes of size 
located at the boundary ∂Ω(t0). We have each microdomain Y centred at
a boundary point form the macroscopic mesh, with the neighbouring -cubes
staring from the centre of the current one (i.e. they are appropriately “half-way
shifted” copies of Y ∈ P∗ ), due to the purposely chosen macroscopic mesh size
h = 2 and the properties of the family P∗Y . Moreover, the centre point of the
microdomains are coincidentally the midpoint induced by Y on [∂Ω(t0)]Y , i.e.
x∗Y .
In order to compute the integrals in the source terms (i.e., f Y1 and f
Y
2 )
in the microscopic system (12) - (15), a midpoint rule is proposed and the
constitutive details are given below. Assuming that K denotes a generic element
domain in a finite element subdivision with either triangular or square elements
of a given region A ⊂ R2, this “midpoint rule” consists of approximating the
integral of a function f over K as the product between the value of f at the
centre of mass of K, Kcentre, and the Lebesgue measure of K, namely,∫
K
f = f(Kcentre)λ(K). (42)
For an arbitrarily chosen Y ∈ P∗ , we consider a finite element approach
involving triangular elements on a uniform micro-mesh, which is maintained
with identical structure for all the micro-domains. Further, we consider a time-
constant approximation f˜ Y1 of f
Y
1 on the time interval [0,∆t]. In this context,
using the computed final-time values of c(·, t0 + ∆t) at the macro-mesh points
that are included on the current microdomain, x1, x2, ..., xPY ∈ Y ∩Ω(t0), we
take:
f˜ Y1 (xs) =
1
λ(B(xs, 2) ∩ Ω(t0))
∫
B(xs,2)∩Ω(t0)
c (xs, t0 + ∆t) dx, (43)
where s = 1, ..., PY , and the integrals are computed via the midpoint rule. For
the rest of the points y on the micro-mesh, the value of f˜ Y1 is obtained in terms
of the set of finite element basis functions considered at the contact points, i.e.
, {φxs |s = 1, ..., PY }. Finally, we observe that for any micro mesh point y ∈ Y
we have two possibilities:
Case 1: If there exists three overlapping points xi1 , xi2 , xi3 ∈ {x1, x2, ..., xPY }
which belongs to the same connected component of Y ∩Ω(t0) and y belongs to
the convex closure of the set, i.e. , y ∈ Conv{xi1 , xi2 , xi3}, then we have:
f˜ Y1 (y) = f˜
Y
1 (xi1)φxi1 (y) + f˜
Y
1 (xi2)φxi2 (y) + f˜
Y
1 (xi3)φxi3 (y). (44)
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Case 2: If y does not satisfies the conditions in Case 1, then we have
f˜ Y1 (y) = 0. (45)
For the source term f Y2 , we use the same approximation method as above,
except that there is only one case taken into consideration which is similar in
equation (44) according to the definition of f Y2 . Now we could obtain the source
terms f˜ Y1 and f˜
Y
2 on each microdomain Y with zero initial condition and
Neumann boundary conditions and furthermore use the finite element method
to solve the reaction-diffusion equations (12) - (15) on Y over the time interval
[0, t0 + ∆t]. Then, we use bilinear elements on a square mesh, the numerical
scheme for the micro processes occurring on each Y is finally obtained by
involving a trapezoidal predictor-corrector method for the time integration.
Then, for each microdomain we use the midpoint rule to compute the tran-
sitional probability described in (37). For simplicity, now the numerical imple-
mentation of the multiscale model for cancer invasion proposed above is slightly
simplified in the following way: provided that the transitional probability ex-
ceeds an associated threshold ωY ∈ (0, 1), the boundary mesh-point x∗Y will
move in direction ηY to the macro-mesh point from ∂Y \[Ω(t0)]Y that is clos-
est (in Euclidean distance) to x∗Y . If the threshold is not satisfied, then x
∗
Y
remains at the same spatial location. Therefore, the new boundary ∂Ω(t0 + ∆t)
is now obtained by the interpolation of the set of points given in (38) , and the
computational process is continued on the new domain Ω(t0 + ∆t) by using as
a discretised version of (39) as a new initial condition at the macroscopic stage,
i.e.,
c(xi,j , t0 + ∆t) =

cki,j , xi,j ∈ Ω(t0),
1
4 (c
k
i−1,j+c
k
i+1,j+c
k
i,j−1+c
k
i,j+1), xi,j ∈ B(Ω(t0), h)\Ω(t0),
0, xi,j /∈ B(Ω(t0), h),
(46)
and,
v(xi,j , t0 + ∆t) = v
k
i,j , u(xi,j , t0 + ∆t) = u
k
i,j ,
p(xi,j , t0 + ∆t) = p
k
i,j , m(xi,j , t0 + ∆t) = m
k
i,j . (47)
where {xi,j i, j = 1, ..., q} is the macroscopic mesh in Y, Ω(t0) is the topological
closure of Ω(t0), and B(Ω(t0), h) represents the topological closure of the h-
bundle of Ω(t0)., i.e., B(Ω(t0), h) := {x ∈ Y |∃zx ∈ Ω(t0) such that ||x− zx||2 ≤
h}.
7.3 Overall algorithm steps
To sum up, the overall algorithm package of the macro-microscopic method
consists of the following steps:
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Step 1: At the very begining time t0, first of all, we discretise the macro-
domain [a, b]× [c, d] by
a = x0, . . . , xi = a+ i∆x, . . . , xm = a+m∆x = b,
c = y0, . . . , yj = c+ j∆y, . . . , yn = c+ n∆y = d.
where ∆x = ∆y = h, h := 2 and let a = c = 0, c = d = 4. Also, we number
each point on the macro-domain, record their coordinates all sorts of data of
the domain that might be used later.
Step 2: Define initial conditions for cancer and ECM distribution on macro-
domain:
c(x, t0) =: c0(x), x ∈ Ω(t0)
v(x, t0) =: v0(x), x ∈ Ω(t0)
u(x, t0) =: u0(x), x ∈ Ω(t0)
p(x, t0) =: p0(x), x ∈ Ω(t0)
m(x, t0) =: m0(x), x ∈ Ω(t0)
where c(x, t0) is set as zero at the mesh points located outside the closure of the
macroscopic domain Ω(t0).
Step 3: Start the main time loop (from time stage 1 to certain time stage N),
and at the current time stage,
a) Run the macro-solver, which applies the finite difference scheme mentioned
above, to obtain the distribution of components in the system cn+1i,j v
n+1
i,j ,
un+1i,j , p
n+1
i,j , and m
n+1
i,j , where i, j = 1, ..., q.
b) Run the micro-solver, in which we loop over each points that was on
the boundary of tumour at previous time, and at an arbitrary boundary
points,
i. Define the micro-domain Y centring at the current point on the
boundary, which consists of nine points on macrodomain. For sim-
plicity, we first construct the domain on [0, ]× [0, ] and on this do-
main compute the source terms f Y1 and f
Y
2 , and by interpolation,
we uniformly decompose the domain into sixty-four square elements
consists of eighty-one points in total, with the source term values and
concentration values for uPA, PAI-1 and plasmin on a finer mesh (see
Figure 13).
ii. On the microdomain Y , apply the finite element method to solve the
microscopic dynamics system (12)-(15), to obtain the spatial distribu-
tion of plasmin at the final micro-time m(·, τf ) (involving a proposed
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midpoint rule formula for the integral source terms f Y1 and f
Y
2 , and
for time integration a trapezoidal predictor-corrector), which will be
used in the regulation functions of cancer cells’ movement.
iii. Translated the coordinates on this microdomain back to where the
micro spatial position was before.
iv. Using the trasitional probability q∗ defined in (37), compute the in-
vasion strength as q∗(x∗Y ) := q
∗(Y ).
v. If and only if the microenvironment induced probability q∗(x∗Y ) is
greater than some tissue threshold value ωY ∈ (0, 1), we further
compute the direction ηY and magnitude ξY of the movement as
described by (35) and (36).
c) Once finishing both macro-solver and micro-solver at the current time
stage, we obtained new macroscopic distribution for each components in
the system cn+1i,j , v
n+1
i,j , u
n+1
i,j , p
n+1
i,j , and m
n+1
i,j ; also for each midpoint x
∗
Y
on the tumour boundary, we have the possibility q∗(x∗Y ), direction ηY
and magnitude ξY of their movement, therefore we could use all these
information to determine the new position x˜∗Y and the points remain
where they were on the cancer interface ∂Ω(t0 +∆t). This is schematically
shown in Figure 13
Figure 13: Plot shows the relocation of one point on the boundary moves to a
new spatial position in the microdomain Y .
where the red dots represent the discrete macro-mesh location for the
where micro-scale source induced by the macro-scale was calculated via
the integral formula (43).
d) Finally, by using approximations shown in (46) and (47), replace the initial
values of cancer and ECM distribution in macroscopic dynamics with the
solution at the final time of the previous macro-step.
Step 4: Using the new initial conditions for macroscopic dynamics, continue
the invasion process by coupling the next-step macro-process given by the system
(6) and (10) on the expand domain Ω(t0 + ∆t) with the corresponding micro
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processes (12) - (15) occurring on its boundary, which means repeating the Step
3 above with new initial conditions for macroscopic dynamics and new boundary
of cancer.
8 Appendix: Table for the parameter set P
In Table 1 we present a description of the parameters included in P.
parameter value description
Dc 4.3× 10−3 diffusion of cancer cells
χu 3.05× 10−2 chemotaxis to uPA
χp 3.75× 10−2 chemotaxis to PAI-1
χv 2.85× 10−2 haptotaxis to ECM(vitronectin)
µ1 0.25 proliferation of cancer cells
δ 1.5 degradation of ECM
φ21 0.75 binding of uPA and PAI-1
φ22 0.55 binding of PAI-1 and VN
µ2 0.01 proliferation of ECM
Du 2.5× 10−3 diffusion of uPA
φ31 0.75 binding of uPA of PAI-1
φ33 0.3 binding of uPA and uPAR
α31 0.215 production of uPA
Dp 3.5× 10−3 diffusion of PAI-1
φ41 0.75 binding of uPA and PAI-1
φ42 0.55 binding of PAI-1 and VN
α41 0.5 production of PAI-1
Dm 4.91× 10−3 diffusion of plasmin
φ52 0.11 increase rate due to binding of PAI-1 and VN
φ53 0.75 increase rate due to binding of uPA and uPAR
φ54 0.5 degradation of plasmin
Table 1: The parameters in P.
References
[1] Abdulle, A., Schwab, C.: Heterogeneous multiscale fem for diffusion prob-
lems on rough surfaces. Multiscale Modeling & Simulation 3(1), 195–220
(2005)
[2] Adam, J.A.: A simplified mathematical model of tumour growth. Math.
Biosci. 81(2), 229–244 (1986)
[3] Allaire, G.: Homogenization and two-scale convergence. SIAM Journal on
Mathematical Analysis 23(6), 1482–1518 (1992)
38
[4] Andasari, V., Gerisch, A., Lolas, G., South, A., Chaplain, M.A.J.: Math-
ematical modeling of cancer cell invasion of tissue: biological insight from
mathematical analysis and computational simulation. J. Math. Biol. 63(1),
141–171 (2011)
[5] Anderson, A., Chaplain, M., Newman, E., Steele, R., Thompson, A.: Math-
ematical modelling of tumour invasion and metastasis. J. Theorl. Medic.
2, 129–154 (2000)
[6] Anderson, A.R.A.: A hybrid mathematical model of solid tumour invasion:
the importance of cell adhesion. Math. Medic. Biol. 22, 163–186 (2005)
[7] Armstrong, N.J., Painter, K.J., Sherratt, J.A.: A continuum approach to
modelling cell-cell adhesion. J. Theor. Biol. 243(1), 98–113 (2006)
[8] Aubert, M., Badoual, M., Fe´reol, S., Christov, C., Grammaticos, B.: A
cellular automaton model for the migration of glioma cells. Physical Biology
3(2), 93 (2006)
[9] Byrne, H., Chaplain, M., Pettet, G., Mcelwain, D.L.S.: A mathematical
model of trophoblast invasion. Appl. Math. Lett. 14(8), 1005–1010 (2001)
[10] Byrne, H., Preziosi, L.: Modelling solid tumour growth using the theory of
mixtures. Math. Medic. Biol. 20, 341–366 (2003)
[11] Byrne, H.M., Chaplain, M.A.: Modelling the role of cell-cell adhesion in
the growth and developement of carcinoma. Math. Comput. Model. 24(12),
1–17 (1996)
[12] Byrne, H.M., Chaplain, M.A.J.: Free boundary value problems associated
with the growth and development of multicellular spheroids. Euro. J. Appl.
Math. 8, 639–658 (1997)
[13] Chaplain, M., Graziano, L., Preziosi, L.: Mathematical modelling of the
loss of tissue compression responsiveness and its role in solid tumour de-
velopment. Math. Medic. Biol. 23, 197–229 (2006)
[14] Chaplain, M., Lachowicz, M., Szymanska, Z., Wrzosek, D.: Mathematical
modelling of cancer invasion: The importance of cell-cell adhesion and cell-
matrix adhesion. Math. Model. Meth. Appl. Sci. 21(4), 719–743 (2011)
[15] Chaplain, M., Lolas, G.: Mathematical modelling of cancer cell invasion
of tissue: the role of the urokinase plasminogen activation system. Math.
Model. Meth. Appl. Sci. 15(11), 1685–1734 (2005)
[16] Chaplain, M., McDougal, S., Anderson, A.: Mathematical modeling of
tumor-induced angiogenesis. Annu. Rev. Biomed. Eng. 8, 233–257 (2006)
[17] Cristini, V., Lowengrub, J., Nie, Q.: Nonlinear simulation of tumour
growth. J. Math. Biol. 46, 191–224 (2003)
39
[18] Deakin, N.E., Chaplain, M.A.J.: Mathematical modelling of cancer cell
invasion: the role of membrane-bound matrix metalloproteinases. Front.
Oncol. 3(70), 1–9 (2013)
[19] Deisboeck, T.S., Wang, Z., Macklin, P., Cristini, V.: Multiscale cancer
modeling. Annu Rev Biomed Eng 13, 127–155 (2011). DOI 10.1146/
annurev-bioeng-071910-124729
[20] Domschke, P., Trucu, D., Gerisch, A., Chaplain, M.: Mathematical mod-
elling of cancer invasion: Implications of cell adhesion variability for tumour
infiltrative growth patterns. J. Theor. Biol. 361, 41–60 (2014)
[21] E, W., Engquist, B.: The heterognous multiscale methods. Communica-
tions in Mathematical Sciences 1, 87–132 (2003)
[22] Frieboes, H.B., Jin, F., Chuang, Y.L., Wise, S.M., Lowengrub, J.S.,
Cristini, V.: Three-dimensional multispecies nonlinear tumor growth—ii:
Tumor invasion and angiogenesis. J. Theor. Biol. 264, 1254–1278 (2010)
[23] Frieboes, H.B., Lowengrub, J.S., Wise, S., Zheng, X., Macklin, P., Bearer,
E.L., Cristini, V.: Computer simulation of glioma growth and morphology.
NeuroImage 37, Supplement 1, S59 – S70 (2007)
[24] Frieboes, H.B., Zheng, X., Sun, C.H., Tromberg, B., Gatenby, R., Cristini,
V.: An integrated computational/experimental model of tumor invasion.
Cancer Res. 66, 1597–1604 (2006)
[25] Gatenby, R.A., Gawlinski, E.T.: A reaction-diffusion model of cancer inva-
sion. Cancer Res. 56, 5745–5753 (1996)
[26] Gatenby, R.A., Gawlinski, E.T., Gmitro, A.F., Kaylor, B., Gillies, R.J.:
Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66,
5216–5223 (2006)
[27] Gerisch, A., Chaplain, M.: Mathematical modelling of cancer cell invasion
of tissue: Local and non-local models and the effect of adhesion. J. Theor.
Biol. 250, 684–704 (2008)
[28] Greenspan, H.P.: On the growth and stabiligy of cell cultures and solid
tumours. J. Theor. Biol. 56, 229–242 (1976)
[29] Halmos, P.: Measure Theory. Springer-Verlag, New York, USA (1974)
[30] Hanahan, D., Weinberg, R.A.: The hallmarks of cancer. Cell 100, 57–70
(2000)
[31] Hanahan, D., Weinberg, R.A.: The hallmarks of cancer: The next genera-
tion. Cell 144, 646–674 (2011)
40
[32] Hillen, T., Painter, K.J.: Convergence of a cancer invasion model to a
logistic chemotaxis model. Math. Model. Meth. Appl. Sci. 23(1), 165–198
(2013)
[33] Ito, E., Ozawa, S., Kijima, H., Kazuno, A., Nishi, T., Chino, O., Shi-
mada, H., Tanaka, M., Inoue, S., Inokuchi, S., Makuuchi, H.: New invasive
patterns as a prognostic factor for superficial esophageal cancer. J. Gas-
troenterol 47, 1279–1289 (2012)
[34] Joyce, J.A., Pollard, J.: Microenvironmental regulation of metastasis. Nat.
Rev. Cancer. 9(4), 239–252 (2009)
[35] Kalluri, R., Zeisberg, M.: Fibroblasts in cancer. Nat. Rev. Cancer. 6(5),
392–401 (2006)
[36] Lin, P.: Convergence analysis of a quasicontinuum approximation for a
twodimensional material without defects. SIAM Journal on Numerical
Analysis 45(1), 313–332 (2007)
[37] Macklin, P., Lowengrub, J.: Evolving interfaces via gradients of geometry-
dependent interior poisson problems: application to tumor growth. J. Com-
put. Phys. 203(1), 191–220 (2005)
[38] Macklin, P., Lowengrub, J.: An improved geometry-aware curvature dis-
cretization for level set methods: application to tumor growth. J. Comput.
Phys. 215(2), 392–401 (2006)
[39] Macklin, P., Lowengrub, J.: Nonlinear simulation of the effect of microen-
vironment on tumor growth. J. Theor. Biol. 245(4), 677–704 (2007)
[40] Macklin, P., Lowengrub, J.: A new ghost cell/level set method for moving
boundary problems: Application to tumor growth. J. Sci. Comput. 35, 266
– 299 (2008)
[41] Macklin, P., McDougall, S., Anderson, A.R.A., Chaplain, M.A.J., Cristini,
V., Lowengrub, J.: Multiscale modelling and nonlinear simulation of vas-
cular tumour growth. J. Math. Biol. 58, 765–798 (2009)
[42] Masuda, R., Kijima, H., Imamura, N., Aruga, N., Nakamura, Y., Ma-
suda, D., Takeichi, H., Kato, N., Nakagawa, T., Tanaka, M., Inokuchi, S.,
Iwazaki, M.: Tumor budding is a significant indicator of a poor prognosis in
lung squamous cell carcinoma patients. Molecular Medicine Reports 6(5),
937–943 (2012)
[43] Mikala, E., S., N.E., Zena, W.: Tumors as organs: Complex tissues that
interface with the entire organism. Developm. Cel. 18(6), 884–901 (2010)
[44] Painter, K.J., Hillen, T.: Spatio-temporal chaos in a chemotaxis model.
Physica D. 240, 363–375 (2011)
41
[45] Perumpanani, A., Sherratt, J., Norbury, J., Byrne, H.: Biological inferences
from a mathematical model for malignant invasion. Invas. Metast. 16(4-5),
209–221 (1996)
[46] Perumpanani, A., Simmons, D., Gearing, A., Miller, K., Ward, G., Nor-
bury, J., Schneemann, M., Sherratt, J.: Extracellular matrix-mediated
chemotaxis can impede cell migration. Proceed. Royal Soci. Biol. Sci.
265(1413), 2347–2352 (1998)
[47] Pop lawski, N.J., Agero, U., Gens, J.S., Swat, M., Glazier, J.A., Anderson,
A.R.A.: Front instabilities and invasiveness of simulated avascular tumors.
Bulletin of Mathematical Biology 71, 1189–1227 (2009)
[48] Preziosi, L., Tosin, A.: Multiphase modelling of tumour growth and extra-
cellular matrix interaction: mathematical tools and applications. J. Math.
Biol. 58, 625–656 (2009)
[49] Qian, B.Z., Pollard, J.W.: Macrophage diversity enhances tumor progres-
sion and metastasis. Cell 141(1), 39–51 (2010)
[50] Ramis-Conde, I., Drasdo, D., Anderson, A.R., Chaplain, M.A.: Modeling
the influence of the e-cadherin-beta-catenin pathway in cancer cell invasion:
a multiscale approach. Biophys. J. 95(1), 155–165 (2008)
[51] Ren, W., E, W.: Heterogeneous multiscale method for the modeling of com-
plex fluids and micro-fluidics. Journal of Computational Physics 204(1), 1
– 26 (2005)
[52] Rubenstein, B.M., Kaufman, L.J.: The role of extracellular matrix in
glioma invasion: A cellular potts model approach. Biophysical Journal
95(12), 5661 – 5680 (2008)
[53] Sabeh, F., Shimizu-Hirota, R., Weiss, S.J.: Protease-dependent versus -
independent cancer cell invasion programs: three-dimensional amoeboid
movement revisited. J. Cell Biol. 185(1), 11–19 (2009)
[54] Smith, H.W., Marshall, C.J.: Regulation of cell signalling by upar. Nat.
Rev. Mol. Cel. Biol. 11, 23–36 (2010)
[55] Stetler-Stevenson, W.G., Aznavoorian, S., Liotta, L.A.: Tumor cell interac-
tions with the extracellular matrix during invasion and metastasis. Annual
Review of Cell Biology 9, 541–573 (1993)
[56] Tektonidis, M., Hatzikirou, H., Chauvie`re, A., Simon, M., Schaller, K.,
Deutsch, A.: Identification of intrinsic in vitro cellular mechanisms for
glioma invasion. Journal of Theoretical Biology 287, 131 – 147 (2011)
[57] Trucu, D., Chaplain, M., Marciniak-Czochra, A.: Three-scale convergence
for processes in heterogeneous media. Applicable Analysis 91(7), 1351–1373
(2012)
42
[58] Trucu, D., Lin, P., Chaplain, M.A.J., Wang, Y.: A multiscale moving
boundary model arising in cancer invasion. Multiscale Model. Simul. 11(1),
309–335 (2013)
[59] Venkatraman, L., Chia, S.M., Narmada, B.C., White, J.K., Bhowmick,
S.S., Jr., C.F.D., So, P.T., Tucker-Kellogg, L., Yu, H.: Plasmin triggers a
switch-like decrease in thrombospondin-dependent activation of tgf-1. Bio-
physical Journal 103(5), 1060 – 1068 (2012)
[60] Webb, S., Sherratt, J., Fish, R.: Alterations in proteolytic activity at low
ph and its association with invasion: a theoretical model. Clin. Experim.
Metast. 17(5), 397–407 (1999)
[61] Wise, S., Lowengrub, J., Friebose, H., Cristini, V.: Three-dimensional mul-
tispecies nonlinear tumor growth - i - model and numerical method. J.
Theor. Biol. 253(3), 524–543 (2008)
[62] Wise, S.M., Lowengrub, J., v. Christini: An adaptive multigrid algorithm
for simulating solid tumor growth using mixture models. Math. Comput.
Model. 53, 1–20 (2011)
[63] Zheng, X., Wise, S., Cristini, V.: Nonlinear simulation of tumor necrosis,
neo-vascularization and tissue invasion via an adaptive finite-element/level-
set method. Bull. Math. Biol. 67(2), 211–259 (2005)
43
